Zafgen announces positive full results in phase 2 clinical trial of ZGN-1061
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Zafgen presents full results of Phase 2 clinical trial for ZGN-1061
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline Updates
Interim Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Anticipated in First Half of 2020Â Â Â Reported Positive Topline Data .....»»
aTyr Pharma Announces Fourth Quarter and Full Year 2018 Results and Provides Corporate Update
Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients initiated in December 2018 First tRNA synthetase partnership announced in March 2019 SAN DIEGO, March .....»»
Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update
Oraxol Phase III clinical trial in metastatic breast cancer fully enrolled Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting A numb.....»»
AbbVie announces "positive" results from Phase 3 SELECT-COMPARE clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VIVUS announces "positive" results from Phase 1 clinical trial of VI-0106
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aldeyra announces "positive" results from Phase 1/2 clinical trial of ADX-1612
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Regulus announces results from Phase 1b clinical trial of RGLS4326
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio announces results from AP-014 Phase I clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam announces full "positive" results from HELIOS-A Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rigel announces results from Phase 2 clinical trial of fostamatinib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Scholar Rock announces top line results from Topaz phase 2 clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Glaukos announces positive phase 3 trial results for iLink
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Recce Pharmaceuticals Announces First-Quarter 2020 Financial Results and Provides Operational Highlights
Highlights: Strong cash position with reserves of AUD $4.09M Formalized a Phase I Clinical trial agreement to conduct a first-in-human study of RECCE® 327 Completed successful in-vivo toxicity st.....»»
Trovagene announces results from Phase 1b/2 clinical trial of onvansertib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Blueprint Medicines announces results from the Phase 3 VOYAGER clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
GENFIT Reports Full-Year 2019 Financial Results and Corporate Update
Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020 Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 31, 2018) Significant milestones achieved i.....»»
IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
- Initial data from Phase 1 trial of IGM-2323 in relapsed/refractory non-Hodgkin's lymphoma expected in the second half of 2020 - - IND filing for IGM-8444 planned in 2020 - - Company to host conference call today at 4:3.....»»
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc.....»»
Hua Medicine Announces 2019 Annual Results
Pivotal Phase III Trial Achieved Clinical Efficacy Endpoint at 24 WeeksDorzagliatin-Driven Portfolio Expands SHANGHAI, China, March 16, 2020 (GLOBE NEWSWIRE) -- Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong Kon.....»»